WO2010008564A3 - Plaice dna transposon system - Google Patents

Plaice dna transposon system Download PDF

Info

Publication number
WO2010008564A3
WO2010008564A3 PCT/US2009/004114 US2009004114W WO2010008564A3 WO 2010008564 A3 WO2010008564 A3 WO 2010008564A3 US 2009004114 W US2009004114 W US 2009004114W WO 2010008564 A3 WO2010008564 A3 WO 2010008564A3
Authority
WO
WIPO (PCT)
Prior art keywords
plaice
transposon system
dna transposon
dna
making
Prior art date
Application number
PCT/US2009/004114
Other languages
French (fr)
Other versions
WO2010008564A2 (en
Inventor
Scott C. Fahrenkrug
Karl J. Clark
Daniel F. Carlson
Michael J. Leaver
Original Assignee
Recombinetics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recombinetics filed Critical Recombinetics
Publication of WO2010008564A2 publication Critical patent/WO2010008564A2/en
Publication of WO2010008564A3 publication Critical patent/WO2010008564A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses

Abstract

This document describes the Passport transposon system and methods of making and using the same.
PCT/US2009/004114 2008-07-16 2009-07-16 Plaice dna transposon system WO2010008564A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8132408P 2008-07-16 2008-07-16
US61/081,324 2008-07-16

Publications (2)

Publication Number Publication Date
WO2010008564A2 WO2010008564A2 (en) 2010-01-21
WO2010008564A3 true WO2010008564A3 (en) 2010-06-10

Family

ID=41550917

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/004114 WO2010008564A2 (en) 2008-07-16 2009-07-16 Plaice dna transposon system

Country Status (2)

Country Link
US (1) US20100105140A1 (en)
WO (1) WO2010008564A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309791B2 (en) 2008-07-16 2012-11-13 Recombinectics, Inc. Method for producing a transgenic pig using a hyper-methylated transposon
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
BR112012020257A8 (en) * 2010-02-11 2018-02-14 Recombinetics Inc methods and apparatus for producing transgenic artiodactyls
US9528124B2 (en) 2013-08-27 2016-12-27 Recombinetics, Inc. Efficient non-meiotic allele introgression
US10920242B2 (en) 2011-02-25 2021-02-16 Recombinetics, Inc. Non-meiotic allele introgression
EP3461898A1 (en) 2011-02-25 2019-04-03 The University Court Of The University of Edinburgh Genetically modified animals and methods for making the same
AR091482A1 (en) 2012-06-21 2015-02-04 Recombinetics Inc GENETICALLY MODIFIED CELLS AND METHODS FOR OBTAINING
US10058078B2 (en) 2012-07-31 2018-08-28 Recombinetics, Inc. Production of FMDV-resistant livestock by allele substitution
US20140115728A1 (en) 2012-10-24 2014-04-24 A. Joseph Tector Double knockout (gt/cmah-ko) pigs, organs and tissues
HUE061494T2 (en) * 2013-02-01 2023-07-28 Selexis Sa Enhanced transgene expression and processing
KR102452767B1 (en) 2013-05-14 2022-10-12 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 Human application of engineered chimeric antigen receptor (car) t-cells
EP3004168A4 (en) 2013-05-24 2017-03-01 Board of Regents, The University of Texas System Chimeric antigen receptor-targeting monoclonal antibodies
ES2962492T3 (en) 2013-10-25 2024-03-19 Livestock Improvement Corporation Ltd Genetic markers and their uses
RU2735700C2 (en) 2015-03-11 2020-11-06 Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем Transposase polypeptides and use thereof
EP4353821A1 (en) * 2022-10-10 2024-04-17 Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft Transposase mutant with enhanced efficiency of gene transfer

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5731178A (en) * 1990-03-21 1998-03-24 Behringwerke Aktiengesellschaft Attachment-elements for stimulation of eukaryotic expression systems
US5346703A (en) * 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US6287792B1 (en) * 1991-06-17 2001-09-11 The Regents Of The University Of California Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology
US5500013A (en) * 1991-10-04 1996-03-19 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5302397A (en) * 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
US6235313B1 (en) * 1992-04-24 2001-05-22 Brown University Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
EP0643600B1 (en) * 1992-06-02 1997-10-15 Alza Corporation Iontophoretic drug delivery apparatus
US5610053A (en) * 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
JP3366069B2 (en) * 1993-09-27 2003-01-14 ファナック株式会社 Piercing control method
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US5891108A (en) * 1994-09-12 1999-04-06 Cordis Corporation Drug delivery stent
US6041252A (en) * 1995-06-07 2000-03-21 Ichor Medical Systems Inc. Drug delivery system and method
US6350780B1 (en) * 1995-07-28 2002-02-26 Allergan Sales, Inc. Methods and compositions for drug delivery
US6068829A (en) * 1995-09-11 2000-05-30 The Burnham Institute Method of identifying molecules that home to a selected organ in vivo
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
US6132765A (en) * 1996-04-12 2000-10-17 Uroteq Inc. Drug delivery via therapeutic hydrogels
US6074673A (en) * 1996-04-22 2000-06-13 Guillen; Manuel Slow-release, self-absorbing, drug delivery system
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6037525A (en) * 1996-08-01 2000-03-14 North Carolina State University Method for reducing expression variability of transgenes in plant cells
US6296621B1 (en) * 1996-08-23 2001-10-02 Baxter International Inc. Receptacle for passive drug delivery
ZA9710342B (en) * 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
CA2280997C (en) * 1997-03-11 2013-05-28 Perry B. Hackett Dna-based transposon system for the introduction of nucleic acid into dna of a cell
US6086582A (en) * 1997-03-13 2000-07-11 Altman; Peter A. Cardiac drug delivery system
US6060082A (en) * 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
US6183444B1 (en) * 1998-05-16 2001-02-06 Microheart, Inc. Drug delivery module
US5972027A (en) * 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
US6083996A (en) * 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
DE69838526T2 (en) * 1998-02-05 2008-07-03 Biosense Webster, Inc., Diamond Bar Device for releasing a drug in the heart
US6086912A (en) * 1998-02-11 2000-07-11 Gilman; Marvin S. Topical drug delivery system
US6309410B1 (en) * 1998-08-26 2001-10-30 Advanced Bionics Corporation Cochlear electrode with drug delivery channel and method of making same
US6251079B1 (en) * 1998-09-30 2001-06-26 C. R. Bard, Inc. Transthoracic drug delivery device
AU6218899A (en) * 1998-10-12 2000-05-01 Geron Bio-Med Limited Porcine oocytes with improved developmental competence
US6395549B1 (en) * 1998-10-22 2002-05-28 Medical College Of Georgia Research Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
US6309380B1 (en) * 1999-01-27 2001-10-30 Marian L. Larson Drug delivery via conformal film
US6235312B1 (en) * 1999-05-14 2001-05-22 Eastman Chemical Company Liquid crystalline phase drug delivery vehicle
US6283947B1 (en) * 1999-07-13 2001-09-04 Advanced Cardiovascular Systems, Inc. Local drug delivery injection catheter
AU1100201A (en) * 1999-10-28 2001-05-08 Board Of Trustees Of The Leland Stanford Junior University Methods of in vivo gene transfer using a sleeping beauty transposon system
JP4609869B2 (en) * 1999-12-03 2011-01-12 独立行政法人科学技術振興機構 Transposon transferase and gene modification method
US6283949B1 (en) * 1999-12-27 2001-09-04 Advanced Cardiovascular Systems, Inc. Refillable implantable drug delivery pump
US6379382B1 (en) * 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
JP2002078491A (en) * 2000-06-22 2002-03-19 National Institute Of Agrobiological Sciences Insertion sequence element derived from ralstonia solanacearum
JP4364474B2 (en) * 2002-02-15 2009-11-18 大学共同利用機関法人情報・システム研究機構 Functional transposons in mammals
DE10224242A1 (en) * 2002-05-29 2003-12-11 Max Delbrueck Centrum Frog Prince, a transposon vector for vertebrate gene transfer
WO2004065581A2 (en) * 2003-01-15 2004-08-05 Discovery Genomics, Inc. Transposon-insulator element delivery systems
US20070204356A1 (en) * 2006-02-28 2007-08-30 University Of Notre Dame Du Lac PiggyBac constructs in vertebrates
US20090042297A1 (en) * 2007-06-01 2009-02-12 George Jr Alfred L Piggybac transposon-based vectors and methods of nucleic acid integration

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
B BENJAMIN ET AL.: "Assembly of the Tcl and mariner transposition initiation complexes depends on the origins of their transposase DNA binding domains", GENETICA, vol. 130, 2007, pages 105 - 120 *
DA YERGEAU ET AL.: "Transgenesis in Xenopus Using the Sleeping Beauty Transposon System", DEVELOPMENTAL DYNAMICS, vol. 238, 12 June 2009 (2009-06-12), pages 1727 - 1743 *
DATABASE EMBL MJ LEAVER: "A family of Tcl-like transposons from the genomes of fishes and frogs: evidence for horizontal transmission", Database accession no. AJ249085.1 *
H LIU ET AL.: "Applications of Sleeping Beauty Transposons for Nonviral Gene Therapy", IUBMB LIFE, vol. 59, no. 6, June 2007 (2007-06-01), pages 374 - 379 *
J TAKEDA ET AL.: "Germline mutagenesis mediated by Sleeping Beauty transposon system in mice", GENOME BIOLOGY, vol. 8, no. 1, 31 October 2007 (2007-10-31), pages 1 - 7 *
L SINZELLE ET AL.: "Generation of trangenic Xenopus laevis using the Sleeping Beauty transposon system", TRANSGENIC RES, vol. 15, 2006, pages 751 - 760 *
MJ LEAVER: "'A family of Tcl-like transposons from the genomes of fishes and frogs: evidence for horizontal transmission", vol. 271, pages 203 - 214 *
Z IVICS ET AL.: "Molecular Reconstruction of Sleeping Beauty, a Tcl-like Transposon from Fish, and Its Transposition in Human Cells", CELL, vol. 91, 14 November 1997 (1997-11-14), pages 501 - 510 *

Also Published As

Publication number Publication date
US20100105140A1 (en) 2010-04-29
WO2010008564A2 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
WO2010008564A3 (en) Plaice dna transposon system
WO2009052431A3 (en) Cd19 binding agents and uses thereof
EP2195961A4 (en) Method and system for providing extended authentication
EP2188958A4 (en) Systems and methods for communicating documents
HUE039505T2 (en) Secure identification document and method for producing it
AP2010005339A0 (en) Desalination system and elements thereof.
ZA200704882B (en) Authentication methods and systems
EP1988485A4 (en) Distributed authentication system and distributed authentication method
IL201728A0 (en) Cascading authentication system
EP2174305A4 (en) Document validation system and method
EP2013812A4 (en) Document security system
EP2374447A4 (en) Water-in-oil emulsified cosmetic
GB0722370D0 (en) Authentication system and method
EP2320691A4 (en) Method for enhancing the security of the multicast or broadcast system
GB2440358B (en) Authentication system and method
WO2008085927A3 (en) Methods, compositions, and kits for the treatment of pain
WO2008103431A3 (en) Dnai - liposomes
EP2138579A4 (en) Reductase, gene thereof and method of using the same
EP2138578A4 (en) Reductase, gene thereof and method of using the same
GB0716479D0 (en) Identity document and method for its manufacture
AU2007903386A0 (en) Desalination process and system
AU2006101032A4 (en) Identity card
AU2007900063A0 (en) System and method for desalination
GB0623638D0 (en) Document modification system, method and document modification system
GB0602079D0 (en) Document Security System

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09798305

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09798305

Country of ref document: EP

Kind code of ref document: A2